In an ideal world, evidence-based medicine and thoughtful clinical research might guide our every treatment decision. But the body of research is sparse on combination therapy for schizophrenia. When is it logical to combine antipsychotics? Dr. Aaron Gibson, assistant professor in the college of pharmacy at the University of New Mexico, joins host Dr. Leslie Lundt to explain when a combination might be reasonable and what problems might occur.